BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 29525205)

  • 1. The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
    Ye Y; Xiang Y; Ozguc FM; Kim Y; Liu CJ; Park PK; Hu Q; Diao L; Lou Y; Lin C; Guo AY; Zhou B; Wang L; Chen Z; Takahashi JS; Mills GB; Yoo SH; Han L
    Cell Syst; 2018 Mar; 6(3):314-328.e2. PubMed ID: 29525205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian clock and cancer therapy: an unexpected journey.
    Kondratov R
    Ann Med; 2014 Jun; 46(4):189-90. PubMed ID: 24915534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian clock and cell cycle: Cancer and chronotherapy.
    Yao J; He C; Zhao W; Hu N; Long D
    Acta Histochem; 2021 Dec; 123(8):151816. PubMed ID: 34800857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian rhythm in pharmacokinetics and its relevance to chronotherapy.
    Dong D; Yang D; Lin L; Wang S; Wu B
    Biochem Pharmacol; 2020 Aug; 178():114045. PubMed ID: 32446886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronopharmacological strategies focused on chrono-drug discovery.
    Ohdo S; Koyanagi S; Matsunaga N
    Pharmacol Ther; 2019 Oct; 202():72-90. PubMed ID: 31173839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian clock synchrony and chronotherapy opportunities in cancer treatment.
    Damato AR; Herzog ED
    Semin Cell Dev Biol; 2022 Jun; 126():27-36. PubMed ID: 34362656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling circadian clock-cell cycle interaction effects on cell population growth rates.
    El Cheikh R; Bernard S; El Khatib N
    J Theor Biol; 2014 Dec; 363():318-31. PubMed ID: 25152215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutics on the clock: Circadian medicine in the treatment of chronic inflammatory diseases.
    Jacob H; Curtis AM; Kearney CJ
    Biochem Pharmacol; 2020 Dec; 182():114254. PubMed ID: 33010213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the link between chronobiology and drug delivery: effects on cancer therapy.
    Albuquerque T; Neves AR; Quintela T; Costa D
    J Mol Med (Berl); 2021 Oct; 99(10):1349-1371. PubMed ID: 34213595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escaping Circadian Regulation: An Emerging Hallmark of Cancer?
    El-Athman R; Relógio A
    Cell Syst; 2018 Mar; 6(3):266-267. PubMed ID: 29596780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments on tumour site-specific chrono-oncology towards personalised treatment.
    Marcu LG
    Crit Rev Oncol Hematol; 2022 Nov; 179():103803. PubMed ID: 36058443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spotlight on Circadian Genes and Colorectal Cancer Crosstalk.
    Rajendran S; Barbon S; Pucciarelli S
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):4-11. PubMed ID: 32579510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian Clock Genes Act as Diagnostic and Prognostic Biomarkers of Glioma: Clinic Implications for Chronotherapy.
    Chai R; Liao M; Ou L; Tang Q; Liang Y; Li N; Huang W; Wang X; Zheng K; Wang S
    Biomed Res Int; 2022; 2022():9774879. PubMed ID: 35832846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian transcriptome of pancreatic adenocarcinoma unravels chronotherapeutic targets.
    Sharma D; Adnan D; Abdel-Reheem MK; Anafi RC; Leary DD; Bishehsari F
    JCI Insight; 2024 May; 9(9):. PubMed ID: 38716727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of Circadian Clock Genes as Significant Clinic Factor in the Tumorigenesis of Hepatocellular Carcinoma.
    Liang Y; Wang S; Huang X; Chai R; Tang Q; Yang R; Huang X; Wang X; Zheng K
    Comput Math Methods Med; 2021; 2021():8238833. PubMed ID: 34745328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The circadian timing system in clinical oncology.
    Innominato PF; Roche VP; Palesh OG; Ulusakarya A; Spiegel D; Lévi FA
    Ann Med; 2014 Jun; 46(4):191-207. PubMed ID: 24915535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronotherapy and the molecular clock: Clinical implications in oncology.
    Innominato PF; Lévi FA; Bjarnason GA
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hair Follicles as a Critical Model for Monitoring the Circadian Clock.
    Liu LP; Li MH; Zheng YW
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies.
    Chang WH; Lai AG
    J Transl Med; 2019 Apr; 17(1):132. PubMed ID: 31014368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.